Bharat Immunologicals (India) Financial Indicators Patterns

BIBCL -- India Stock  

INR 13.84  0.41  3.05%

You can use fundamental analysis to find out if Bharat Immunologicals is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found twenty-four available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Current Valuation, Gross Profit, Debt to Equity, as well as the relationship between Price to Book and Cash and Equivalents . Use Bharat Immunologicals to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Bharat Immunologicals to be traded at 16.61 in 30 days

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Tata Consultancy, Tata Consultancy, Reliance Industries, Reliance Industries, and HDFC Bank. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and traded on Bombay Stock Exchange.

Bharat Immunologicals Current Ratio vs Return On Asset

Bharat Immunologicals Biologicals Corp Ltd is rated third in current ratio category among related companies. It is rated below average in return on asset category among related companies .

Bharat Immunologicals Systematic Risk

The output start index for this execution was twelve with a total number of output elements of five. The Beta measures systematic risk based on how returns on Bharat Immunologicals correlated with the market. If Beta is less than 0 Bharat Immunologicals generally moves in the opposite direction as compared to the market. If Bharat Immunologicals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bharat Immunologicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bharat Immunologicals is generally in the same direction as the market. If Beta > 1 Bharat Immunologicals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Bharat Immunologicals Financial Distress Probability

1% 
Chance of Financial Distress
Bharat Immunologicals Biologicals Corp Ltd has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Bharat Immunologicals

Compare Bharat Immunologicals To Peers

Bharat Immunologicals Opportunity Range

October 20, 2018 Opportunity Range

Check also Trending Equities. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com